Galectin-4 was strongly expressed in LUAD patients with lymph node metastasis and was associated with aggressive cancer traits such as lymphatic and venous invasion, although it did not correlate with overall or recurrence-free survival (34). The gene discussed is LGALS4; the disease is metastatic malignant neoplasm in the lymph nodes.